Hostname: page-component-6766d58669-zlvph Total loading time: 0 Render date: 2026-05-16T18:49:23.286Z Has data issue: false hasContentIssue false

Surgical treatment of glottic cancer: retrospective analysis of 192 cases in a multidisciplinary tertiary care centre in Pune, India

Published online by Cambridge University Press:  16 February 2015

D S Kelkar*
Affiliation:
Division of Surgical Oncology, Deenanath Mangeshkar Hospital and Research Centre, Pune, India
S S Gandhi
Affiliation:
Division of Surgical Oncology, Deenanath Mangeshkar Hospital and Research Centre, Pune, India
G A Oka
Affiliation:
Department of Research, Deenanath Mangeshkar Hospital and Research Centre, Pune, India
*
Address for correspondence: Dr D S Kelkar, Division of Surgical Oncology, Deenanath Mangeshkar Hospital, Erandawane, Pune – 411004, MS, India E-mail: dskelkar@gmail.com

Abstract

Objectives:

A multidisciplinary team approach is required for the preservation of voice and appropriate management of glottic cancer. This study aimed to investigate the outcomes of surgically treated glottic cancers of all stages. All aspects of surgical management, such as laser cordectomy, partial laryngectomy, total laryngectomy with voice prosthesis, and salvage laryngectomy, conducted at a single tertiary care institute in India, were reviewed.

Method:

A retrospective analysis of hospital records was performed for 192 glottic cancer patients who were surgically treated between 2003 and 2007.

Results:

Patients with tumour stages 1 or 2 glottic cancer treated with laser cordectomy had a local control rate of 85 per cent and five-year survival rate of 98.6 per cent. The findings suggest that the number of partial laryngectomies performed for stage 3 tumours is declining. Patients with a tumour stage 3 lesion with a fixed hemilarynx or a tumour stage 4 lesion, treated with total laryngectomy, were found to have a five-year survival rate of 61.6 per cent. Nodal status was significantly associated with five-year survival rate.

Conclusion:

Surgery offers a viable five-year survival rate in glottic cancer patients.

Information

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable